Search

Your search keyword '"Hashiramoto, Mitsuru"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Hashiramoto, Mitsuru" Remove constraint Author: "Hashiramoto, Mitsuru"
44 results on '"Hashiramoto, Mitsuru"'

Search Results

5. SNAREing GLUT4 at the Plasma Membrane in Muscle and Fat

8. Molecular mechanism by which pioglitazone preserves pancreatic [beta]-cells in obese diabetic mice: evidence for acute and chronic actions as a PPAR[gamma] agonist

9. The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3

11. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

15. Molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity

18. Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes.

19. Seven-year Observational Study on the Association between Glycemic Control and the New Onset of Macroangiopathy in Japanese Subjects with Type 2 Diabetes

20. Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)

22. Anti-hypertensive azelnidipine preserves insulin signaling and glucose uptake against oxidative stress in 3T3-L1 adipocytes

26. Molecular Analysis of db Gene-related Pancreatic .BETA. Cell Dysfunction; Evidence for a Compensatory Mechanism Inhibiting Development of Diabetes in the db Gene Heterozygote

28. A Pilot Study Suggests that the G/G Genotype of Resistin Single Nucleotide Polymorphism at -420 May Be an Independent Predictor of a Reduction in Fasting Plasma Glucose and Insulin Resistance by Pioglitazone in Type 2 Diabetes

30. The G/G Genotype of a Resistin Single-Nucleotide Polymorphism at −420 Increases Type 2 Diabetes Mellitus Susceptibility by Inducing Promoter Activity through Specific Binding of Sp1/3

35. Hypertrophic Cardiomyopathy in Patients with Diabetes Mellitus Associated with Mitochondrial tRNALeu(UUR) Gene Mutation.

36. Human Obese Gene.

39. [Hypoglycemia].

40. [Sulfonylurea-pioglitazone combination agent].

42. [A target of PPARgamma agonist: diabetes mellitus].

43. [Drug-induced hypoglycemia].

44. [Mutations in the insulin receptor gene].

Catalog

Books, media, physical & digital resources